COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,155 Articles (22,703 medRxiv, 8,452 bioRxiv)

Most recent first Previous |  Page 215: Articles 2141-2150  | Next

Behavior-driven forecasts of neighborhood-level COVID-19 spread in New York City
Zhang, R., Tai, J., Yao, Q., Yang, W., Ruggeri, K., Shaman, J., Pei, S.
10.1101/2024.04.17.24305995 — Posted: 2024-04-19
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China: a genomic epidemiology study
Fu, P., Yan, G., Li, Y., Li, X., Ke, Y., Qiu, S., Wu, S., Shi, X., Qin, J., Zhou, J., Yang, C., Wang, C.
10.1101/2024.04.16.24305932 — Posted: 2024-04-19
Changes in life expectancy and life span equality during the COVID-19 epidemic in Japan up to 2022.
Okada, Y., Nishiura, H.
10.1101/2024.04.18.24306049 — Posted: 2024-04-19
Early Detection of Novel SARS-CoV-2 Variants from Urban and Rural Wastewater through Genome Sequencing and Machine Learning
Zhuang, X., Vo, V., Moshi, M., Dhede, K., Ghani, N., Akbar, S., Chang, L., Young, A. K., Buttery, E., Bendik, W., Zhang, H., Afzal, S., Moser, D., Cordes, D., Lockett, C., Gerrity, D., Kan, H.-Y., Oh, E. C.
10.1101/2024.04.18.24306052 — Posted: 2024-04-19
Immunogenicity and safety of an Omicron XBB.1.16 adapted vaccine for COVID-19: Interim results from a randomized, controlled, non-inferiority clinical trial
Lopez Fernandez, M. J., Narejos, S., Castro, A., Echave-Sustaeta, J. M., Forner, M. J., Arana-Arri, E., Molto, J., Bernad, L., Perez-Caballero, R., Prado, J. G., Raich-Regue, D., Boreika, R., Izquierdo-Useros, N., Blanco, J., Puig-Barbera, J., Natalini Martinez, S.
10.1101/2024.04.19.24306064 — Posted: 2024-04-19
Comparative Analysis of COVID-19 Serological testing methods to Polymerase Chain Reaction: A systematic review and meta-analysis
Chisompola, D., Maleti, A., Tembo, K. M., Banda, T., Chishinji, G. M., Phiri, R.
10.1101/2024.04.18.24305918 — Posted: 2024-04-19
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
Ackerman, A., Fichter, C., Ison, T., Esneau, C., Milogiannakis, V., Ruiz Silva, M., Lopez, J., Bartlett, N., Darley, D., Amatayakul-Chantler, S., Ellis, S., Dwyer, D., Kok, J., Sintchenko, V., Matthews, G., Murrell, B., Naing, Z., Caguicla, J., Roth, N., Manni, S., Hauser, T., Barnes, T., Boss, T., Condylios, A., Yeang, M., Sato, K., Rawlinson, W., Promsri, S., Stark, D., Marris, K., Gosbell, I., Hoad, V., Kelleher, A., Knight, E., Brilot, F., Wood, J., Aggarwal, A., Turville, S.
10.1101/2024.04.18.24305862 — Posted: 2024-04-19
PAbFold: Linear Antibody Epitope Prediction using AlphaFold2
DeRoo, J., Terry, J. S., Zhao, N., Stasevich, T. J., Snow, C., Geiss, B. J.
10.1101/2024.04.19.590298 — Posted: 2024-04-19
Discovery and Synthesis of GS-7682, a Novel Prodrug of a 4'-CN-4-Aza-7,9-Dideazaadenosine C-Nucleoside with Broad-Spectrum Potency Against Pneumo- and Picornaviruses and Efficacy in RSV-Infected African Green Monkeys.
Siegel, D. S., Hui, H. C., Pitts, J., Vermillion, M. S., Ishida, K., Rautiola, D., Keeney, M., Irshad, H., Zhang, L., Chun, K., Chin, G., Goyal, B., Doerffler, E., Yang, H., Clarke, M. O., Palmiotti, C., Vijjapurapu, A., Riola, N. C., Stray, K., Murakami, E., Ma, B., Wang, T., Zhao, X., Xu, Y., Lee, G., Marchand, B., Seung, M., Nayak, A., Tomkinson, A., Kadrichu, N., Ellis, S., Barauskas, O., Feng, J. Y., Perry, J. K., Perron, M., Bilello, J., Kuehl, P. J., Subramanian, R., Cihlar, T., Mackman, R. L.
10.1101/2024.04.17.589937 — Posted: 2024-04-19
Ubiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L
Zhu, K., Chatrin, C., Suskiewicz, M., Aucagne, V., Ahel, D., Ahel, I.
10.1101/2024.04.19.590267 — Posted: 2024-04-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).